Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study. - Wikidata - wikimedia - TriplyDB

Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study.

Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study.

http://www.wikidata.org/entity/Q34122878

about

Biomarkers for assessing disease activity in inflammatory bowel disease The role of peroxisome proliferator-activated receptor γ in immune responses to enteroaggregative Escherichia coli infection.Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriateness.Upregulation of calprotectin in mild IgE-mediated ovalbumin hypersensitivity.Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.The role and utility of faecal markers in inflammatory bowel disease.Fecal Calprotectin is an Accurate Tool and Correlated to Seo Index in Prediction of Relapse in Iranian Patients With Ulcerative Colitis.Fecal calprotectin concentrations in healthy children aged 1-18 months Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group.Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis.Fecal Calprotectin in Healthy Children Aged 1-4 Years.Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use.Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sjögren's syndrome and rheumatoid arthritis.Advances in the diagnosis and management of inflammatory bowel disease: challenges and uncertainties.Monitoring of therapy for inflammatory bowel disease.C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.Noninvasive Markers of Disease Activity in Inflammatory Bowel Disease.Comparison of Fecal Inflammatory Markers in Crohn's Disease.Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease.Evaluation of a Multiplex Real-Time PCR Assay for Detecting Major Bacterial Enteric Pathogens in Fecal Specimens: Intestinal Inflammation and Bacterial Load Are Correlated in Campylobacter Infections.A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease.Low faecal haemoglobin concentration potentially rules out significant colorectal disease.Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care.FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel disease.Elevated fecal calprotectin in patients with Alzheimer's dementia indicates leaky gut.Increased fecal calprotectin levels in Crohn's disease correlate with elevated serum Th1- and Th17-associated cytokines.Fecal Calprotectin: A Comparison of Two Commercial Enzymoimmunoassays and Study of Fecal Extract Stability at Room Temperature.

P2860

Q24202614-D7B2E487-52D0-44A1-ADF7-BB0F5BE0208F Q30422017-5475112A-1E6A-4A20-8BBA-DCD2B862E1A6 Q33613034-F3274B87-A766-4050-8EB2-74D06051F409 Q33913941-99AEB6A8-C8F8-49F2-A3ED-04CF55BF2B9F Q34413480-0DD12CA0-858A-4DA8-9296-1E9CFED6B5AD Q34456258-88083B8B-0B2B-47AA-B387-37B26D1C6941 Q35157904-FDBED282-1B8B-4883-B470-2C2E0AFA7167 Q35572083-C79D8B49-54CD-4A79-B517-6963AE895CEE Q35849043-25310AA0-3428-461D-920D-4E2FDB7EB343 Q36477478-B7216FE8-8DC6-4357-AF40-BC29EB3DFA35 Q36614247-34E63A46-3A37-4EDC-86B1-54430068219E Q36659252-991AAD60-6C09-4B58-9EB8-F6AF55862BFF Q37618733-6269A218-DCDE-44F2-961C-EC416C0FB1B8 Q37689925-874C07E0-47DD-45F3-A6C6-8A0E811AE431 Q37703514-50CCC490-108C-4806-8225-8A86CF913CBC Q38050877-3EDC870B-7532-4249-ADD7-5B387D4D49DF Q38474301-A9CBBE9A-FE00-4341-BFFB-E90F2128FBC2 Q39464033-D34FDCA1-67E6-42B5-B173-A663E8A695B0 Q40052049-A0B9191A-75B0-43ED-A20D-461B6DAF74D0 Q40432830-3855CEF0-B2E9-4748-AA6C-752B61E5CE46 Q40979275-37761C74-77FC-49F5-A58C-94124839E556 Q43794455-447A03A8-1C52-4249-93AE-6EF586AFF9FE Q44142884-622DE1C7-AC61-45A7-BB93-D682FA16E8ED Q45720232-5F9AE6BF-6925-4104-BDB7-C7BC535101C1 Q51021353-DCEF7F70-E386-4134-83C8-8247184AAF0C Q51511994-39FB3DD5-1903-4763-A083-FD6DF040C72B Q52676637-AA7229DB-D9ED-4B95-A0FB-CE4D15308777 Q53473409-EC421F34-7565-4B4C-B241-AD0C0EB4AAB8 Q55221315-7B14479F-F2EF-460C-903B-DFB6FD745378 Q55397418-777A73D0-B066-49B0-8F6E-9DF5DA983ADA

P2860

Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study.

http://www.wikidata.org/entity/Q34122878

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Value of fecal calprotectin in ...... mfort: an observational study.

@ast

Value of fecal calprotectin in ...... mfort: an observational study.

@en

Value of fecal calprotectin in ...... mfort: an observational study.

@nl

type

label

Value of fecal calprotectin in ...... mfort: an observational study.

@ast

Value of fecal calprotectin in ...... mfort: an observational study.

@en

Value of fecal calprotectin in ...... mfort: an observational study.

@nl

prefLabel

Value of fecal calprotectin in ...... mfort: an observational study.

@ast

Value of fecal calprotectin in ...... mfort: an observational study.

@en

Value of fecal calprotectin in ...... mfort: an observational study.

@nl

P1433

Q34122878-73570C78-2096-47D6-8ACA-214007710CC2

P1476

Q34122878-772FE504-1A3A-4D1C-A663-DD7D4200FFB4

P2093

Q34122878-51E2C08F-A983-4D21-AAA0-1E6721D20F38

Q34122878-5DAC9CA0-B56B-49D5-8EE9-078A16273DB6

Q34122878-61812E94-D1FD-42AA-B037-2D56958B06D6

Q34122878-682AB77C-B604-41E9-98EE-E016CB2BD3A7

Q34122878-6B6189DA-38AC-4136-AD42-BCEE3DDBAD38

Q34122878-8F81BF58-460C-4C82-90C4-8CAA28FF6000

Q34122878-B576ED52-BE6A-482C-B97A-7E3F4E597162

Q34122878-CAA73FB7-A795-498C-8FAF-B2E296166B76

P2860

Q34122878-0273C972-E901-4ABE-B3D2-17C78AF228D6

Q34122878-040A6CA5-AF62-443C-9FDF-68A0A3C28066

Q34122878-07D51446-1863-4173-9307-67D7F5592113

Q34122878-07F12D69-514A-4B0F-AF12-7FC7DB1A5380

Q34122878-145E8B21-3BF7-4E7C-BEEA-827BCBFCB525

Q34122878-169DA999-56BC-4784-8377-4C0A7A47F25F

Q34122878-188CFFD2-17F3-44BE-A834-CD6F8B433093

Q34122878-1EC0F02A-167B-4A70-81FE-5883307C5C32

Q34122878-2A0B4DE8-5EE4-4997-B42E-47EF58B624B6

Q34122878-2DA25F10-821A-4D3D-866B-5767E057467E

P2888

Q34122878-32EF1D3C-90C0-4404-BFD1-5E6030CEE0C0

P304

Q34122878-925A428A-A72C-4F34-B0A1-F9745FD95C2D

P31

Q34122878-7E84AF5B-A02A-4D58-85BF-21B103BE7362

P356

Q34122878-DB844D10-1934-4FC7-8BA6-3D1E1F999C25

P478

Q34122878-765969AD-D5B6-4F4A-978E-FB3554264AC2

P577

Q34122878-DC854C9F-41FA-4791-8B22-E6A4433F34EE

P5875

Q34122878-3C006E8C-402C-4A0B-BEF6-0E6FE5D50CA2

P6179

Q34122878-26FF46E9-8D80-4266-A610-537B4F2C982E

P698

Q34122878-72455D1B-BA9D-4F36-9E37-C4A00816CA1C

P921

Q34122878-095464E4-6A0C-4590-ACF3-E49F45364EDA

Q34122878-F1AF883D-14B4-4A27-8326-65CBDC0A03FB

P932

Q34122878-2F68F356-9978-47AA-B171-64DB5708BD95

P356

P1433

BMC Gastroenterology

P1476

Value of fecal calprotectin in ...... mfort: an observational study.

@en

P2093

Christian Niederberger

http://www.w3.org/2001/XMLSchema#string

Christoph Beglinger

http://www.w3.org/2001/XMLSchema#string

Claude Rothen

http://www.w3.org/2001/XMLSchema#string

Emanuel Burri

http://www.w3.org/2001/XMLSchema#string

Frank Serge Lehmann

http://www.w3.org/2001/XMLSchema#string

Livio Rossi

http://www.w3.org/2001/XMLSchema#string

Michael Manz

http://www.w3.org/2001/XMLSchema#string

Nuschin Tchanguizi

http://www.w3.org/2001/XMLSchema#string

P2860

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis

Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children

Functional gastroduodenal disorders

The yield of colonoscopy in average-risk patients with non-specific colonic symptoms.

Appropriateness and diagnostic yield of EGD: a prospective study in a large Asian hospital.

Appropriateness of colonoscopy: diagnostic yield and safety in guidelines.

Patterns of endoscopy in the United States: analysis of data from the Centers for Medicare and Medicaid Services and the National Endoscopic Database.

The European Panel on Appropriateness of Gastrointestinal Endoscopy (EPAGE): project and methods.

Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.

Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement.

P2888

P304

5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-230X-12-5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221736711

http://www.w3.org/2001/XMLSchema#string

P6179

1007931497

http://www.w3.org/2001/XMLSchema#string

P698

22233279

http://www.w3.org/2001/XMLSchema#string

P921

P932

3267677

http://www.w3.org/2001/XMLSchema#string